Fig. 1.
Representative molecules exhibiting anxioselective profiles in preclinical models. Among the nine compounds illustrated here, six (bretazenil, abecarnil, alpidem, ocinaplon, MRK 409, TPA023, TPA 023B) were advanced to the clinic.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.